Positive Phase 2 trial interim analysis on safety and efficacy for denovoSkin™ in pediatric burn patients
May 27, 2025 | Company
CUTISS has completed an interim analysis in its Phase 2 clinical trial evaluating the safety and efficacy of den...
Read more >
Ayar Labs Bets on Silicon Photonic Technology and Taiwan’s Chip Ecosystem
May 25, 2025 | Company
AI systems are growing fast. As models get bigger, chips need to move more data than ever. But the way chips tal...
Read more >
CUTISS and Tecan partner to advance the automation of bioengineered human skin tissue manufacturing
April 14, 2025 | Company
CUTISS announced a strategic partnership with Tecan, a global leader in the development, production, and distrib...
Read more >
betPawa ranks first in Acquisition Power Score among iGaming brands in regulated markets for 2024
February 12, 2025 | Company
According to the latest study by Blask, the AI-driven iGaming analytics ecosystem, betPawa’s total Acquisition...
Read more >
Positive Phase 2 trial readout for long-term efficacy & safety of denovoSkin™ in reconstructive skin surgery and in burns
| Company
CUTISS announced positive long-term efficacy and safety readout in the Phase 2 clinical trials of denovoSkin™ ...
Read more >
Nvidia, AMD and Intel Invest in Startup Bringing Light to Chips
December 11, 2024 | Company
Ayar Labs Inc., which specializes in using light to transfer data between chips, scored investment from the thre...
Read more >